What if AI stopped giving answers on a screen and started running actual experiments in a real laboratory?
That is exactly what Anthropic is doing.
The AI company has confirmed that it now operates a wet biology lab in the Bay Area, a physical laboratory where scientists can carry out real-world biological experiments with support from AI models.
For a long time, many AI leaders have talked about how artificial intelligence could completely change healthcare and help scientists find cures for diseases much faster. Anthropic CEO Dario Amodei recently made a bold statement, saying he believes AI could help cure most major diseases within the next five to ten years.
But there is one important thing people often forget.
No matter how smart an AI model becomes, it cannot cure diseases by simply generating answers. At some point, those ideas have to be tested in the real world. Scientists need to run experiments, collect results, and confirm that the theories actually work.
That is where Anthropic's biology lab comes in.
According to Anthropic's Head of Life Sciences, Eric Kauderer-Abrams, biology still depends on real laboratory work. Speaking to Reuters, he explained that the final test in biology is still done inside a lab, and Anthropic is already doing that today.
He also explained that the facility operates much like a typical biotech laboratory. Some of the research is conducted internally by Anthropic, while other projects involve collaborations with external research partners.
Honestly, this development is not completely surprising.
Back in April, Anthropic acquired Coefficient Bio, a stealth AI biotech company. Looking back now, that move appears to have been part of a bigger plan to strengthen its presence in biological research.
One thing Anthropic is making clear, however, is that its lab is not focused on creating drugs.
The company says its main area of interest is fundamental biology, which means understanding how biological systems work at a deeper level rather than directly developing medicines.
There is also a business reason behind that decision.
Anthropic works with several pharmaceutical companies and biotech organizations, and it does not want to create the impression that it is competing against its own customers. The company recently announced a partnership with Novo Nordisk to collaborate on drug discovery, and it has faced criticism in the past when some of its products appeared to overlap with what customers were already offering.
Alongside the lab announcement, Anthropic also introduced a new Life Sciences Verification Program. The goal is to give verified biological researchers access to its most advanced AI models.
The company has also been publishing research showing how AI could support scientific breakthroughs. Some of its recent work focuses on speeding up protein design and improving biomolecular modeling, areas that play a major role in understanding diseases and developing future treatments.
For now, Anthropic's wet lab may be focused on basic biological research, but it represents something bigger. It shows that AI companies are no longer interested in only generating ideas. They are increasingly looking for ways to test those ideas in the real world.
And if AI is truly going to help transform medicine one day, this is probably what that journey looks like.
